What does Oberland Capital invest in?
Oberland Capital invests most often at Debt and Series B (100% of the rounds on record), in sectors such as Healthcare and Life Sciences.

United States · Investor
Last cheque observed Jan 2026; 5 cheques on record.
Deploying nowNew fund $10M, Nov 2025Private credit
1 cheques in the last 12 months
Mostly Debt and Series B: 100% of its rounds
Sole investor in 4 rounds, median $145M
Oberland Capital’s broad suite of creative financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investments in traditional debt and equity.From their own website
Every round we can evidence, newest first5 appearances
1 round
2 rounds
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
We also hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
8 private funds, $3.1B in gross assets · filed Mar 2024
Private equity 7Hedge 1
From their own portfolio page (on their website)
COMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCOMPANYCompanyCompanyCompanyCompany
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The latest companies Oberland Capital put money into.
Oberland Capital invests most often at Debt and Series B (100% of the rounds on record), in sectors such as Healthcare and Life Sciences.
5 investments on record, 1 of them in the last 12 months, and it led 3. The most recent was in Jan 2026.
Its most recent investments on record: Primmune Therapeutics (Series B, Jan 2026), BillionToOne (Debt, Sept 2024) and ImmunityBio, Inc. (Undisclosed round, Jan 2024).
The median round it joins is $140M. It says it writes cheques of $50M to $300M.
Yes: it led 3 of its 5 investments on record (60%).
Most of the companies it backs are in the United States (100%).
Yes: it is actively investing, with 1 investments in the last 12 months.
Oberland Capital is a private credit firm based in New York, United States.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it